SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celgene-CELG -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (338)9/3/1999 9:10:00 AM
From: Mike K  Respond to of 804
 
Miljenko; Thank you for your kind wishes!

I started this week with 50mg of thalidomide a day increasing to 200mg over the next 2 weeks. This is a clinical trial with thalidomide as the only agent for patients with early stage disease.

Multiple Myeloma is finally getting the attention and research dollars that have been lacking for far too long.

Best Wishes,

Mike (Long CELG)